Chicago, IL – November 10, 2022 – Svoboda Capital Partners LLC (“SC”), is pleased to announce that it has exited its investment in Clarion Healthcare, LLC (“Clarion” or the “Company”), which has been acquired by Lumanity, LLC (“Lumanity”), a global leader in accelerating and optimizing patient access to medical advances. SC and the Clarion management team will retain an ongoing minority equity stake in Lumanity. Specific terms of the transaction were not disclosed.

Clarion, founded in 2003 and based in Boston, MA, provides strategic and organizational consulting services to life sciences companies. As part of its client engagements, Clarion helps pharma and biotech companies envision the opportunity for their assets, craft strategies to ensure success, and enable organizational excellence to realize value creation opportunities. Clarion serves clients spanning the size spectrum – from leading global enterprises to emerging firms seeking to commercialize their first asset. Over the years, Clarion has developed deep therapeutic area domain expertise, with a strong presence in oncology, rare diseases, and other specialty therapeutic areas, including ophthalmology, dermatology, and endocrinology, among others.

“SC has been a strategic thought partner and has provided unique insights given their experience partnering with other professional services organizations. Our partnership with SC proved to be a catalyst for growth and we are excited to build upon our strong foundation to continue growing our business,” said Tom Murtagh, CEO of Clarion. “We are grateful of SC’s support, and we look forward to continuing our Svoboda relationship as we become part of Lumanity and continue to find unique ways to help our client’s bring new treatments to market.”

Svoboda Capital Partners originally recapitalized Clarion in partnership with management in October 2020. “On behalf of SC, it has been a pleasure to work with the Clarion team and help them in their efforts to become a best-in-class life sciences strategy and organizational consultancy,” said Will King, Vice President at Svoboda Capital Partners. “We are proud of our affiliation with an incredible organization, and we look forward to following Clarion’s success as part of Lumanity.”

For more information on Clarion, please visit www.clarionhealthcare.com.

For more information on Lumanity, please visit www.lumanity.com.